卡培他滨治疗进展期三阴乳腺癌疗效分析.pdf

Abstract the and of inroutine observe efficacysafetycapecitabine Background：To forunselectedadvanced cancer(TNBC)． clinical tnplenegative-breast practice with Patientsand advancedTNBC treated Methods：Forty．fivepatients werecollected．The side rates，progression‘freesurvival(PFS)，and capecitabine response were effectsanalyzed． 60％andmedian Results：Overall progression-free responserate(ORR)was atbaselineWasa was7．75months．Good status survival performance significantpredictor intervalafter not of significant surgery(p。0．198)was efficacy(p=0．005)．Relapse—free PFS．Themostcommon Washand·foot of toxicity syndrome， predictor and Myelosuppression． gastrointestinalresction treatment isa andwelltolerated feasible，effective Conclusions：Capecitabine inreal—lifeclinical with for TNBC．Our favorably advanced findings practicecompare studies． resultsfrominterventional cance